Inve India ▾

Vasa Denticity share price & results

Vasa Denticity Limited· Healthcare

Results to
Jun 2026
Latest analysed call
Q1 FY27
Ownership as of
Sept 2026

India's largest online dental-commerce and technology platform selling consumables, equipment and instruments to dentists, with an in-house dental lab (Smileworks) and digital case-management tools.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue82.2 ₹ crore+36.9% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin6.2 %+0.9 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit4.2 ₹ crore+46.0% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity7.56 %−11.4 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin-11.19 %−0.8 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)17.89 %—Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

0 of 3 judged targets kept · 11 open · verdicts reflect calls analysed to Q1 FY27.

Vasa Denticity Limited management guidance track record on Inve: 14 targets tracked across analysed earnings calls (0 achieved, 3 missed, 11 open).

TargetOriginal wordingSaidLatest callVerdict
Late Deliveries (SLA breach)Reduce from 13% to 6-7% within FY26
Call transcript, Q4 FY25 · 23 May 2025		Q4 FY25Q1 FY27:No update was provided on the specific SLA breach percentage metric. The target deadline has passed.
Call transcript, Q1 FY27 · 12 Aug 2026		Ghosted
Gross Margin26% to 30% going forward
Call transcript, Q4 FY25 · 23 May 2025		Q4 FY25Q1 FY27:After missing the target, management issued new, slightly higher long-term guidance of 27-30% gross margin, citing operational repairs and a lighter cost base.
Call transcript, Q1 FY27 · 12 Aug 2026		Revised Up
EBITDA MarginsMove back towards the mid-teens over time
Call transcript, Q2 FY26 · 17 Nov 2025		Q2 FY26Q1 FY27:Management reported improving gross margins and a lighter cost base, with expectations of decreasing opex per order, supporting the path to margin recovery.
Call transcript, Q1 FY27 · 12 Aug 2026		On Track

Source: Inve Guidance Tracker for Vasa Denticity Limited · to Q1 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

3 of Vasa Denticity Limited's 14 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 11 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹422.4 −2.58% · −₹11.2

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance −29.7% 1Y

₹400₹500₹600Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 17 Nov 2025Q4 FY26 — 5 Jun 2026Q1 FY27 — 12 Aug 2026

1Y: ₹601.1 on 24 Oct 2025 → ₹422.4. High ₹609.5 (7 Nov 2025), low ₹336.7 (30 Mar 2026).

Previous close
₹433.6
Market cap
₹746 Cr
52-week range
₹336.7 – ₹609.5
One year
−30.37%
Price to earnings (TTM to Jun 2026)
64.31×
Return on equity (TTM to Jun 2026)
7.56%

Overview

Symbol
NSE:DENTALKART
Exchange
NSE
Currency
INR

What Vasa Denticity Limited does

Based on the company's own presentations, annual report and earnings calls.

Dentalkart (operated by Vasa Denticity Limited) runs an e-commerce marketplace for dental professionals, selling consumables, equipment and instruments sourced through a vetted direct-procurement network of manufacturers and importers, supported by its own warehouses and last-mile delivery. It also owns Smileworks Labs, a dental-prosthetics lab, and offers the VASA Dental Cloud Platform for digital case management, order processing and lab integration. Revenue is earned primarily from product sales (consumables, equipment, instruments) on the platform, supplemented by lab/prosthetics services.

Segments

  • Consumables
  • Equipment
  • Instruments
  • Dental lab services (Smileworks Labs)
  • Digital platform / clinical software
Product catalogue (SKUs)
23,000+
Dental professionals on platform
2.7 lakh+ (H1 FY26)
Brands on platform
470+ (H1 FY26)
Warehouses
8, totalling ~57,775 sq ft (FY25)
Monthly active users
4.54 lakh+ (H1 FY26)
Average delivery time
~4.2 days (Q2 FY26)
Headquarters New Delhi, India Company website

How the price took the results

close before → close after

Q1 FY27
−3.0%
12 Aug
Q4 FY26
−1.1%
5 Jun
Q2 FY26
+0.7%
17 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Vasa Denticity Limited

Free account: one company. Everything above stays public.

Write why you follow Vasa Denticity Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Healthcare companies

All Healthcare companies → · Healthcare earnings growth →

Learn to analyse Vasa Denticity Limited

Guides on how to read this kind of business and the numbers that matter.